Thus, this CRISPR-Cas9 screening unveils a novel tumor vulnerability of energy metabolism, and the involvement of Jun and Myc in NTRK fusion-induced tumorigenesis, together confirming the validity of the multiomics integrative approach to discover master regulators. The gene discussed is JUN; the disease is neoplasm.